DM
Dennis Mulroy
Chief Financial Officer

Dennis Mulroy insider trades: Anaptysbio (ANAB) stock buys and sales

Chief Financial Officer, Anaptysbio Last trade Jan 7, 2026 65 Form 4 filings
$1.4M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2017
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Dennis reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 7, 2026ANAB↓ Sell$86K
Jan 5, 2026ANAB↓ Sell$145K
Dec 22, 2025ANAB↓ Sell$500K
Dec 16, 2025ANAB↓ Sell$705K
Sep 16, 2024ANAB↓ Sell$488K
May 22, 2024ANAB↓ Sell$36K
Jan 30, 2024ANAB↓ Sell$72K
Jan 8, 2024ANAB↓ Sell$48K
Sep 18, 2023ANAB↓ Sell$116K
Mar 3, 2017LJPC↑ Buy$17K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANAB insiders

Open-market trades in the last 12 months

About Dennis Mulroy's insider trades

Dennis Mulroy is Chief Financial Officer at Anaptysbio (ANAB). Since Mar 3, 2017, Dennis has reported 1 open-market purchase worth $17K and 9 sales worth $2.2M on SEC Form 4. In the last 12 months: 4 sales ($1.4M).

Their filings also include grants and awards (55 filings), option exercises (8 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.